Urges Them to Vote the WHITE Proxy Card and Elect All Three of Its
Nominees Who Are Committed To Acting In Shareholders’ Best Interests
Eastbourne Capital Management, L.L.C....
SAN DIEGO, April 21 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc.
(Nasdaq: AMLN) today reported financial results for the quarter ended March
31, 2008....
SAN DIEGO, Nov. 21 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) will be presenting at its Research & Development (R&D) Day on Wednesday, November 28, 2007...
- Both Groups Experienced Significant Weight Loss -
- New Drug Application Filing Planned by the End of the First Half of 2009 -
SAN DIEGO, INDIANAPOLIS, and CAMBRIDGE, Mass., Oct. 31...
#4: Amylin Pharmaceuticals to Webcast Third Quarter Results and Gilead Submits Marketing Applications in the United States and European Union for Viread(R) (Tenofovir Disoproxil Fumarate) for the Treatment of Chronic Hepatitis B
Biotechnology industry alert provided by U.S. Equity News. Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) will webcast its Quarterly Update Conference Call for the third quarter of 2007 on...
SAN DIEGO, Oct. 11 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) will webcast its Quarterly Update Conference Call for the third quarter of 2007 on Wednesday,...
Biotechnology industry alert provided by U.S. Equity News. Medarex, Inc. (Nasdaq: MEDX) recently announced that it is scheduled to present at the Natixis Bleichroeder's Hidden Gems...
SAN DIEGO, INDIANAPOLIS and CAMBRIDGE, Mass.--(BUSINESS WIRE)--Aug. 22, 2005--Amylin Pharmaceuticals, Inc., (Nasdaq: AMLN), Eli Lilly and Company (NYSE: LLY) and Alkermes, Inc. (Nasdaq: ALKS) today...